Danaher Corporation (NYSE:DHR – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $164.96 and last traded at $165.31, with a volume of 333449 shares. The stock had previously closed at $166.26.
Wall Street Analysts Forecast Growth
DHR has been the subject of several research reports. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. Robert W. Baird lowered their target price on Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research note on Friday, April 17th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. Wells Fargo & Company decreased their price objective on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 22nd. Finally, Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Eighteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average price target of $240.70.
Read Our Latest Research Report on Danaher
Danaher Stock Performance
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period in the prior year, the firm posted $1.88 EPS. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. As a group, analysts anticipate that Danaher Corporation will post 8.43 earnings per share for the current year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.0%. Danaher’s payout ratio is 30.95%.
Insider Buying and Selling
In related news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares in the company, valued at $1,060,642.99. This represents a 20.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 10.80% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
A number of institutional investors have recently modified their holdings of DHR. Elevated Capital Advisors LLC purchased a new position in Danaher during the 4th quarter worth $26,000. Hilton Head Capital Partners LLC acquired a new position in shares of Danaher during the fourth quarter worth about $27,000. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 53 shares during the period. JPL Wealth Management LLC purchased a new position in Danaher during the third quarter worth about $25,000. Finally, Main Street Group LTD acquired a new stake in Danaher in the first quarter valued at about $25,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- Plug Power Flips The Switch On Profitability
- 3 Sectors That Look Most Vulnerable Ahead of May 15
- Qualcomm Stock Doubles: New Era? Or Another False Start?
- 3 Industrial Stocks That Just Crushed Earnings
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
